I'm not sure that's an entirely fair comparison.
TER got lucky with their BA acquisition from Rio in 2016.
SMR got lucky with their acquisition from BMC (mostly BHP) in 2022. If SMR hadn't gotten lucky in 2022, they would not be in their position today. And there wouldn't be that nice chart.
The other two Queenslanders who didn't get lucky are BCB and CRN.
So as bad as I think TER management is, life is tough unless you get lucky.
Now this might surprise... but I can sort of accept TER management sitting on their hands.
The thing about their non-BA assets in Australia is I don't think they can spend any money on them. Or rather, what's the point? Queensland isn't going to let anyone develop them anyway. (This includes Moorlands because it would've been developed by now if it was profitable to do so. It's been around for a long time.)
As for SA, I'm not sure that's a better use of capital than just returning to shareholders. They can't even offload their existing SA assets at an okay price. So why invest more?
- Forums
- ASX - By Stock
- Ann: Wintime Cooperation Agreement
I'm not sure that's an entirely fair comparison.TER got lucky...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TER (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.0¢ |
Change
0.010(4.55%) |
Mkt cap ! $180.2M |
Open | High | Low | Value | Volume |
22.0¢ | 23.5¢ | 21.5¢ | $683.1K | 3.009M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 776753 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 0.225 |
14 | 693525 | 0.220 |
8 | 268377 | 0.215 |
8 | 92138 | 0.210 |
5 | 117024 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 776753 | 4 |
0.235 | 309709 | 5 |
0.240 | 138719 | 10 |
0.245 | 369243 | 5 |
0.250 | 249445 | 13 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
TER (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online